You are here: Home » Investments » NESTA Ventures » Investments portfolio » Life Sciences and Healthcare portfolio » Haemostatix

Haemostatix

Haemostatix logo

Summary

Haemostatix Ltd is developing their lead product, a safe substitute for Platelet Transfusion, for treatment of potentially life threatening bleeding in patients with platelet deficiency.

Sector: Healthcare

Website: http://www.haemostatix.com/

Related press release: 

Investors back development of synthetic platelet substitute

 

Investments

 

 

 

 


 

Site by Underwired*

© 2008 NESTA